From The Blog

• Galenica’s Ovixan® receives positive review by Nordic Authorities

  

  Galenica AB’s new pharmaceutical product for treatment of Psoriasis and Eczema, Ovixan®, received on Thursday the 15th of December a … Read more »

• Merry Christmas and a Happy New Year

  

  We wish our clients and friends a Merry Christmas and a Happy New Year. Our Christmas donation this year goes … Read more »

• A step closer to trials without errors

  

  At some stages pharmaceutical research and development is a question of trial and error. But when it comes to clinical … Read more »